论文部分内容阅读
Objective: To assess the clinical efficacy,safety,and risk factors influencing local tumor progression,following transarterial embolization simultaneously combined with CT-Guided radiofrequency ablation(RFA)for recurrent or residual hepatocellular carcinoma(HCC).Methods: Between January 1,2015 and December 30,2015,107 patients with recurrent or residual hepatocellular carcinoma(tumor size 10-50 mm)were followed >1 years or until death.